Literature DB >> 22502953

Paradoxical response to tuberculosis treatment in a patient receiving tumor necrosis factor-alpha antagonist.

Caroline Moureau, Lucie Pothen, Dunja Wilmes, Jean Cyr Yombi, Emmanuel Coche, Philippe Hainaut.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2012        PMID： 22502953     DOI： 10.1016/j.amjmed.2012.02.006

Source DB:  PubMed          Journal:  Am J Med        ISSN： 0002-9343            Impact factor:   4.965


× No keyword cloud information.
  3 in total

1.  Relapsed Pulmonary Cryptococcosis during Tumor Necrosis Factor α Inhibitor Treatment.

Authors:  Takahiro Takazono; Toyomitsu Sawai; Masato Tashiro; Tomomi Saijo; Kazuko Yamamoto; Yoshifumi Imamura; Taiga Miyazaki; Naofumi Suyama; Koichi Izumikawa; Hiroshi Kakeya; Katsunori Yanagihara; Hiroshi Mukae; Shigeru Kohno
Journal:  Intern Med       Date:  2016-10-01       Impact factor: 1.271

2.  Paradoxical response to disseminated non-tuberculosis mycobacteriosis treatment in a patient receiving tumor necrosis factor-α inhibitor: a case report.

Authors:  Takahiro Takazono; Shigeki Nakamura; Yoshifumi Imamura; Taiga Miyazaki; Koichi Izumikawa; Hiroshi Kakeya; Katsunori Yanagihara; Shigeru Kohno
Journal:  BMC Infect Dis       Date:  2014-02-28       Impact factor: 3.090

Review 3.  Use of steroids to treat anti-tumor necrosis factor α induced tuberculosis-associated immune reconstitution inflammatory syndrome: Case report and literature review.

Authors:  Daijiro Nabeya; Takeshi Kinjo; Kazutaka Yamaniha; Shoshin Yamazato; Reo Tome; Kazuya Miyagi; Hideta Nakamura; Tetsu Kinjo; Shusaku Haranaga; Futoshi Higa; Jiro Fujita
Journal:  Medicine (Baltimore)       Date:  2020-10-23       Impact factor: 1.817
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.